3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic thinkers from every conceivable marketing background.

Bristol Myers Squibb’s Opdivo (nivolumab) has been approved by the US Food and Drug Administration (FDA) as part of a ...

Chiesi Group has announced the operational launch of its biotech centre of excellence in Italy. The company has invested ...

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to only a few ...

Diversity and inclusion are critical to business success, particularly when fostering innovation and creativity. At Mednet, ...

GSK has received a recommendation from the European Medicines Agency’s human medicines committee for a single-vial, fully liquid presentation of its meningococcal vaccine Menveo. The new presentation, ...

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

We recently had the privilege of attending the European Society for Medical Oncology (ESMO). With over 40,000 oncology professionals from 177 countries, ESMO stands as a global leader in oncology ...

With World Heart Day just having passed (29th September), Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, Medscape hosted 6 ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell immunotherapy, Carvykti (ciltacabtagene autoleucel), in previously-treated multiple ...

Johnson & Johnson’s (J&J) Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission (EC) as a long-term treatment for pulmonary ...